Physician profile
Amanda Rutherford
NPI 1942783428
$410.37
in general payments reported to CMS, 2019-2025
15 companies · $41.29 in 2025
The $41.29 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $109 · 2023: $110 · 2024: $150 · 2025: $41.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $48.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.83 | 2023-2024 | |
| Pfizer INC. | $45.57 | 2023 | |
| Astellas Pharma US INC | $32.57 | 2024 | Veozah |
| Organon LLC | $32.11 | 2024 | |
| Merck Sharp & Dohme LLC | $30.08 | 2022-2024 | Gardasil, Gardasil 9 |
| Mayne Pharma Commercial LLC | $29.87 | 2023 | |
| Sumitomo Pharma America, INC. | $26.20 | 2025 | Myfembree |
| Olympus America INC. | $22.67 | 2024 | Olympus |
| Exeltis, USA INC. | $19.49 | 2024 | Slynd |
| Axonics, INC. | $16.51 | 2022 | |
| Ethicon US, LLC | $15.36 | 2022 | |
| Acadia Pharmaceuticals INC | $15.09 | 2025 | Daybue |
| Hologic Sales and Service, LLC | $14.76 | 2022 | |
| Boston Scientific Corporation | $13.55 | 2023 | Obtryx System - Curved |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rutherford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.